Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of Aspergillus galactomannan antigen testing with a new cut-off index and Aspergillus precipitating antibody testing for the diagnosis of chronic pulmonary aspergillosis.
Kitasato Y, Tao Y, Hoshino T, Tachibana K, Inoshima N, Yoshida M, Takata S, Okabayashi K, Kawasaki M, Iwanaga T, Aizawa H. Kitasato Y, et al. Among authors: yoshida m. Respirology. 2009 Jul;14(5):701-8. doi: 10.1111/j.1440-1843.2009.01548.x. Respirology. 2009. PMID: 19659648
Prevalence of asthma with airflow limitation, COPD, and COPD with variable airflow limitation in older subjects in a general Japanese population: the Hisayama Study.
Matsumoto K, Seki N, Fukuyama S, Moriwaki A, Kan-o K, Matsunaga Y, Noda N, Yoshida M, Koto H, Takata S, Nakanishi Y, Kiyohara Y, Inoue H; Hisayama Pulmonary Physiology Study Group. Matsumoto K, et al. Among authors: yoshida m. Respir Investig. 2015 Jan;53(1):22-9. doi: 10.1016/j.resinv.2014.08.002. Epub 2014 Oct 1. Respir Investig. 2015. PMID: 25542600
Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial.
Machida K, Kawayama T, Kinoshita M, Ichinose M, Tsuda T, Takata S, Koto H, Yoshida M, Ashihara Y, Kawashima M, Suna H, Inoue H. Machida K, et al. Among authors: yoshida m. Int J Chron Obstruct Pulmon Dis. 2019 Sep 19;14:2175-2184. doi: 10.2147/COPD.S223002. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31571853 Free PMC article. Clinical Trial.
11,104 results
You have reached the last available page of results. Please see the User Guide for more information.